L-Carnitine for Metabolic Flexibility
Carnitine supports fat oxidation biochemically, but human trials show only modest metabolic effects and unreliable weight change.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 2 g twice daily L-carnitine L-tartrate taken with a carbohydrate-rich meal, for 12-24 weeks
- Expected timeframe
- 12-24 weeks
Protocol
- form
- L-carnitine L-tartrate. Avoid D-carnitine and DL-carnitine, which are harmful
- duration
- 12-24 weeks - muscle carnitine content changes only over months
- co factor
- Take with a large carbohydrate load. Muscle carnitine uptake is insulin-dependent, and without a strong insulin stimulus oral carnitine raises plasma levels without changing muscle content at all. Evidence is mixed. The Stephens and Wall studies showed that 2 g twice daily with around 80 g carbohydrate for 12-24 weeks raises muscle carnitine roughly 20% and shifts substrate use - sparing glycogen at low intensity and increasing its use at high intensity, which is the textbook definition of improved metabolic flexibility. That is a real finding, but it comes from a small number of studies by a single group, requires an impractical daily carbohydrate load, and has not translated into consistent body composition or performance outcomes elsewhere.
- titration
- Do not exceed 4 g/day total
- starting dose
- 2 g twice daily with meals containing substantial carbohydrate
Evidence
What the studies say
L-carnitine supplementation, muscle carnitine content and fuel metabolism during exercise
Wall BT, Stephens FB, Constantin-Teodosiu D +3 more
Carnitine feeding raised muscle carnitine content and altered fuel selection
Safety
Caveats
Metabolic flexibility responds far more to training - particularly zone 2 endurance work and resistance training - and to weight loss and sleep than to any supplement. Safety ceiling: doses above 3 g/day commonly cause nausea, vomiting, abdominal cramps, diarrhoea and a fishy body odour; keep below 4 g/day. Note the loading protocol itself adds several hundred carbohydrate calories daily. The TMAO concern applies to long-term use: gut bacteria convert carnitine to trimethylamine, which the liver oxidises to TMAO, a metabolite associated in prospective cohorts with cardiovascular events; significance unresolved but a reason for caution with prolonged high doses, particularly with existing cardiovascular disease. Carnitine may potentiate warfarin - monitor INR. Avoid in seizure disorders, where increased seizure frequency has been reported, and in hypothyroidism, where it may antagonise thyroid hormone action. Use cautiously in kidney disease, where carnitine accumulates. Insufficient safety data in pregnancy and breastfeeding - avoid in both.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.